XML 59 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Statements Of Cash Flows - USD ($)
shares in Millions, $ in Millions
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Cash flows from operating activities:    
Net earnings $ 224.5 $ 243.2
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 433.7 264.4
Share-based compensation expense 50.3 32.5
Change in estimated sales allowances 6.2 337.1
Deferred income tax provision (76.3) (92.9)
Loss from equity method investments 49.7 43.0
Other non-cash items 142.9 107.4
Litigation settlements, net 16.8 26.3
Changes in operating assets and liabilities:    
Accounts receivable (140.3) (249.0)
Inventories (231.4) (178.2)
Trade accounts payable 77.4 0.6
Income taxes (151.0) (9.5)
Other operating assets and liabilities, net (20.8) (77.4)
Net cash provided by operating activities 381.7 447.5
Cash flows from investing activities:    
Capital expenditures (122.0) (153.3)
Cash paid for acquisitions, net 0.0 (33.0)
Proceeds from sale of property, plant and equipment 0.0 5.0
Purchase of marketable securities (51.6) (10.5)
Proceeds from sale of marketable securities 21.6 7.8
Payments for product rights and other, net (115.8) (135.3)
Net cash used in investing activities (267.8) (319.3)
Cash flows from financing activities:    
Payment of financing fees (83.6) (2.6)
Change in short-term borrowings, net 105.6 (193.3)
Proceeds from convertible note hedge 667.9 0.0
Proceeds from issuance of long-term debt 305.0 240.0
Payment of long-term debt (973.6) (300.0)
Proceeds from exercise of stock options 86.4 29.9
Taxes paid related to net share settlement of equity awards (31.7) (22.8)
Acquisition of noncontrolling interest (10.6) 0.0
Other items, net 48.0 21.3
Net cash provided by (used in) financing activities 113.4 (227.5)
Effect on cash of changes in exchange rates (13.1) 1.9
Net increase (decrease) in cash and cash equivalents 214.2 (97.4)
Cash and cash equivalents — beginning of period 225.5 291.3
Cash and cash equivalents — end of period $ 439.7 $ 193.9
Non-cash transaction:    
Ordinary shares issued for acquisition 6,305.8 0.0